Barely Significant
← all excerpts

Targeting WFS1 overcomes KRAS<sup>G12D</sup> dependency and adaptive resistance to KRAS inhibition in pancreatic cancer.

NPJ Precis Oncol · 2026 · PMC13282380 · PMID 42298062

Europe PMCDOI
1
hedged sentence
—
closest p
—
boldest claim

The sentences

showed a trendno p-value reported
1C ), and Kaplan–Meier analysis showed a trend toward reduced overall survival among patients exhibiting higher WFS1 expression (Fig. 1D ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.